Kane Biotech Inc. (CVE:KNE – Get Free Report)’s stock price traded down 4.2% on Tuesday . The stock traded as low as C$0.12 and last traded at C$0.12. 20,000 shares changed hands during trading, a decline of 84% from the average session volume of 124,956 shares. The stock had previously closed at C$0.12.
Kane Biotech Price Performance
The company has a current ratio of 0.82, a quick ratio of 0.39 and a debt-to-equity ratio of 1,164.24. The firm has a market cap of C$15.24 million, a P/E ratio of -4.00 and a beta of 0.52. The company has a fifty day moving average price of C$0.12 and a two-hundred day moving average price of C$0.13.
Kane Biotech Company Profile
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Featured Stories
- Five stocks we like better than Kane Biotech
- What Are Dividend Challengers?
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
- Differences Between Momentum Investing and Long Term Investing
- 3 S&P 500 Stocks With Sky High Risk-Adjusted Returns
- What Are Some of the Best Large-Cap Stocks to Buy?
- Trending Stocks: How to Spot, Trade, and Profit Safely
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
